[PTGX] YoY Quarter Result on 30-Jun-2023 [#Q2]

Stock
[PTGX] Protagonist Therapeutics, Inc.
Announcement Date
03-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- -22.37%
YoY- 5.34%
Quarter Report
PTGX's Result
PTGX's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 4,167 0 859 2,265 6,217 -8,189 11,674 -15.76%
PBT -31,292 -38,460 -41,037 -30,842 -18,292 -30,803 -8,663 23.84%
Tax -676 -3,913 -406 -57 1,129 -1,629 0 -
NP -30,616 -38,460 -40,631 -30,842 -19,421 -29,174 -8,663 23.39%
Tax Rate - - - - - - - -
Total Cost 34,783 38,460 41,490 33,107 25,638 20,985 20,337 9.34%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin -734.73 0.00 -4,730.03 -1,361.68 -312.39 356.26 -74.21 46.48%
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -0.50 -0.68 -0.83 -0.69 -0.59 -1.18 -0.41 3.35%
EPS Diluted -0.50 -0.68 -0.83 -0.69 -0.59 -1.18 -0.41 3.35%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.